v.kjaer

TL2 · Mombasa

Contributes reviews on supplier material. Based in Mombasa.

Joined 30 August 2025 · last posted 3d

82 posts, newest first. Showing up to 150.

Transit times by route, from a logged dataset Replied, post #33 · Sourcing › Logistics · 25 Jul 2026 · 28 likes Building on post #32 rather than restating it. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until…
Which categories are strict and which are relaxed, honestly Replied, post #48 · Start Here › Welcome · 25 Jul 2026 · 31 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #65 · Access › Insurance & coverage · 25 Jul 2026 · 6 likes This follows post #62 rather than contradicting it. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria.…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #28 · Clinical › Prescriber conversations · 21 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Why the Start Here categories exist, and what they are not for Replied, post #13 · Start Here › Welcome · 19 Jul 2026 · 32 likes No notes. Posting so the count is not one.
Substitution between formats during a shortage — what changed since Replied, post #17 · Access › Shortages · 17 Jul 2026 · 6 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #42 · Practice › Dosing & titration · 6 Jul 2026 · 12 likes Post #38 describes the usual case. This is about the unusual one. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
Journal club: what we got wrong in an earlier session Replied, post #56 · Evidence › Journal club · 5 Jul 2026 · 4 likes Post #55 is right about the mechanism and I think understates the practical bit. Reading order that works for these sessions: registry entry, methods, baseline table,…
How to ask a question when you cannot say why you are asking it Replied, post #16 · Start Here › How to Ask · 18 Jun 2026 · 4 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. The specific question in the title is more useful than you might think. A title…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #5 · Clinical › Bloodwork · 16 Jun 2026 · 32 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #13 · Practice › Storage & stability · 30 May 2026 · 17 likes Building on post #10 rather than restating it. Practical experience of Mean kinetic temperature, offered as one case with the conditions stated, not as a general…
Revisiting: Patterns that reliably precede a problem, documented Replied, post #21 · Sourcing › Red flags · 23 May 2026 · 13 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. It is the kind of…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #38 · Wellbeing › Sleep · 19 May 2026 · 2 likes Adding the measurement that post #36 says would settle it. When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens,…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #42 · Practice › Administration · 18 May 2026 · 32 likes Noted, and I have changed what I was going to do on the strength of it.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #117 · Analytics › Mass spectrometry · 26 Apr 2026 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #76 · Practice › Reconstitution · 22 Apr 2026 · 7 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #10 · Practice › Administration · 21 Apr 2026 · 9 likes Adding the measurement that post #7 says would settle it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #68 · Data & Tools › Calculators · 10 Apr 2026 · 0 likes Adding the measurement that post #67 says would settle it. A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because…
List price versus negotiated price versus what you pay Replied, post #30 · Access › Pricing · 10 Apr 2026 · 20 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. Scoping that…
Injection volume, overload, and peak distortion — one year on Replied, post #9 · Analytics › HPLC & UHPLC · 6 Apr 2026 · 16 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #81 · Lounge › Introductions · 16 Mar 2026 · 1 like No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
A site rotation scheme that is easy enough to actually follow Replied, post #19 · Practice › Administration · 13 Mar 2026 · 0 likes The practical value of a written technique note to yourself is that it survives a three-week gap. Everyone who has come back after a break has rediscovered something…
Citation sweep results: how many references did not say what was claimed Replied, post #59 · Meta › Wiki maintenance · 12 Mar 2026 · 0 likes Citation sweep results would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Five questions in one post gets you one answer — how to split them Replied, post #26 · Start Here › How to Ask · 7 Mar 2026 · 7 likes I would call the community position on five questions likely rather than established, and I would be comfortable defending that hedge.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #34 · Compounds › Tirzepatide · 5 Mar 2026 · 6 likes Everything in post #30 holds. The case it does not cover is the one I have. On 2.5 mg starting dose, I would rather understate and be corrected upward than overstate…
The lowest dose that does anything: is that a real question? Replied, post #50 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. Reaching a dose and staying there for a year: the question of whether a stable dose…
Foaming during reconstitution and whether it matters — the long version Replied, post #51 · Practice › Reconstitution · 3 Mar 2026 · 6 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #7 · Research Methods › N-of-1 designs · 22 Feb 2026 · 4 likes I have been on both sides of the ABAB design argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #18 · Practice › Reconstitution · 19 Feb 2026 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. Having read the whole Choosing a concentration thread before replying: the question in…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 13 Feb 2026 · 17 likes Adding the measurement that post #5 says would settle it. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #76 · Documentation › Wiki requests · 7 Feb 2026 · 0 likes Scope the request narrowly. A page about one thing gets written and stays current; a page about a field does not. Genuinely open to being wrong about this one.
Trifluoroacetate content and its consequences Replied, post #18 · Analytics › Impurities & related substances · 24 Jan 2026 · 11 likes Posting my trifluoroacetate content numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Coming back to: Training through a dose escalation week Replied, post #5 · Nutrition & Training › Resistance training · 8 Jan 2026 · 11 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #86 · Compounds › Semaglutide · 5 Jan 2026 · 11 likes Confirming post #85 from a second method, which matters more than confirming it from a second person. Having read the whole semaglutide half-life thread before…
Cardiovascular risk: reading the outcome trials as a set Replied, post #2 · Clinical › Comorbidities · 15 Dec 2025 · 5 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #35 · Access › Pricing · 12 Dec 2025 · 9 likes Post #32 answers the question as asked. The question underneath it is different. Where a price includes consultation, device and follow-up, saying so makes a comparison…
Where the integrator drew the baseline, and how much it moved the number Replied, post #23 · Analytics › HPLC & UHPLC · 29 Nov 2025 · 17 likes Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as evidence of identity is not a valid comparison.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #28 · Compounds › Other compounds · 23 Nov 2025 · 1 like On post #26 — agreed on the reasoning, with one qualification. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
Pen dose counters: what a click does and does not guarantee Replied, post #11 · Devices › Pens & autoinjectors · 12 Nov 2025 · 0 likes Post #7 put the caveat in the right place and I want to underline it. Autoinjectors that fire on skin contact remove the technique variable almost entirely, which is…
[2026 update] What steady state means for the decision to escalate Replied, post #36 · Practice › Dosing & titration · 8 Nov 2025 · 2 likes Post #32 describes the usual case. This is about the unusual one. Checked the steady state claim against the primary source this morning. It survives, with a narrower…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #28 · Sourcing › Regulatory · 30 Oct 2025 · 0 likes Picking up post #25: that is the part I would want checked first. A compound in a compounding pathway in one country and unavailable in another is a common situation…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #105 · Compounds › Tirzepatide · 23 Oct 2025 · 10 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #147 · Practice › Reconstitution · 18 Oct 2025 · 0 likes Confirming post #146 from a second method, which matters more than confirming it from a second person. Two people can reconstitute the same vial to different…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #133 · Practice › Side effects · 9 Oct 2025 · 5 likes Nausea timeline is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #47 · Compounds › Oral incretins · 9 Oct 2025 · 2 likes I had written a reply contradicting post #46 and deleted it. Here is what survived. Oral bioavailability is variable between people. Some people absorb well; others…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #132 · Evidence › Study critique · 16 Sep 2025 · 0 likes Taking post #130 at face value and following it one step further. A request rather than an answer: could whoever has the primary source for Reverse causation post it? I…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #5 · Evidence › Study critique · 12 Sep 2025 · 26 likes The opening post put the caveat in the right place and I want to underline it. Hold a trial to the standard something could actually have met. A criticism that no…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #50 · Documentation › Doc review · 1 Sep 2025 · 14 likes Reporting rather than recommending, on Promotion criteria. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #119 · Practice › Reconstitution · 20 Aug 2025 · 14 likes I had written a reply contradicting post #117 and deleted it. Here is what survived. For anyone finding this later: the short answer on reconstituting a multi-strength…
Enforcement priorities versus written rules — does this still hold? Replied, post #20 · Sourcing › Regulatory · 20 Aug 2025 · 19 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Import rules for personal quantities differ from commercial import…
Cross-border purchase rules within the EU Replied, post #3 · Regional › European Union · 20 Aug 2025 · 0 likes Answering the cross-border purchase rules within question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it…
Adolescents: a distinct evidence base — one year on Replied, post #10 · Clinical › Special populations · 19 Aug 2025 · 0 likes Answering the question post #6 raises rather than the one it answers. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
A request that was declined, and the reasoning — a second dataset Replied, post #25 · Documentation › Wiki requests · 8 Aug 2025 · 13 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. Filing this under things that are true…
Revisiting: List price versus negotiated price versus what you pay Started this topic · Access › Pricing · 31 Jul 2025 · 32 likes Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. Working notes on List price…
Counter-ion content and its effect on measured mass Replied, post #88 · Analytics › Mass spectrometry · 10 Jul 2025 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Managing an unplanned gap in supply — what changed since Replied, post #7 · Access › Shortages · 26 Jun 2025 · 29 likes Adding the measurement that post #6 says would settle it. I would call the community position on Managing an unplanned gap likely rather than established, and I would…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #32 · Compounds › Repair & healing peptides · 6 Jun 2025 · 2 likes No notes. Posting so the count is not one.
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #31 · Practice › Dosing & titration · 1 Jun 2025 · 19 likes Post #30 put the caveat in the right place and I want to underline it. A titration plan written down in advance is easier to stick to and easier to abandon…
Cost per milligram, computed honestly across formats — the long version Replied, post #113 · Access › Pricing · 25 May 2025 · 20 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #71 · Practice › Reconstitution · 16 May 2025 · 12 likes Everything in post #67 holds. The case it does not cover is the one I have. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved…
Follow-up: The decimal-point error, and the habit that catches it Started this topic · Practice › Reconstitution · 13 May 2025 · 38 likes On the subject in the title: The decimal-point error, and the habit that catches it Working notes rather than a conclusion. A follow-up question about decimal-point…
Carryover and the ghost peak from last week's standard Replied, post #13 · Analytics › HPLC & UHPLC · 2 Apr 2025 · 1 like Post #11 put the caveat in the right place and I want to underline it. For anyone finding this later: the short answer on carryover is that it depends on one thing, and…
Retatrutide dose escalation in the published trials Replied, post #61 · Compounds › Retatrutide · 28 Mar 2025 · 1 like Picking up post #58: that is the part I would want checked first. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #71 · Sourcing › Red flags · 27 Mar 2025 · 2 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
Triple agonism: additive, synergistic, or neither? Replied, post #29 · Compounds › Retatrutide · 23 Mar 2025 · 9 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Coverage for the indication versus for the drug Replied, post #6 · Access › Insurance & coverage · 21 Mar 2025 · 7 likes Quantity limits are a separate decision from coverage and have their own exception route.
A ten-fold dose error caught before injection Replied, post #9 · Devices › Syringes & needles · 14 Mar 2025 · 3 likes Silicone coating on the barrel affects how smoothly the plunger moves and how a very slow injection feels. It is one reason two syringes at the same specification are…
Review: a draft on reconstitution arithmetic, with objections Replied, post #50 · Documentation › Doc review · 8 Mar 2025 · 1 like Confirming post #48 from a second method, which matters more than confirming it from a second person. Reviewing your own nomination is fine and is not sufficient.…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #91 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #67 · Access › International · 27 Feb 2025 · 0 likes Taking post #66 at face value and following it one step further. The confident answers on Cross-border purchase within and the well-sourced answers are not the same…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #17 · Evidence › Meta-analyses · 28 Jan 2025 · 13 likes Answering the question post #15 raises rather than the one it answers. Individual participant data pooling is a much stronger design than aggregate pooling and is rare…
Why mass spectrometry cannot tell you about an epimer Replied, post #25 · Analytics › Mass spectrometry · 12 Jan 2025 · 29 likes Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at trace level may be telling you about the preparation…
Body image changing more slowly than the body Replied, post #115 · Wellbeing › Mental health · 23 Dec 2024 · 30 likes Agreed on body image, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
Building a sensible monitoring schedule with your prescriber Replied, post #7 · Clinical › Bloodwork · 18 Dec 2024 · 2 likes Checked the building a sensible monitoring schedule claim against the primary source this morning. It survives, with a narrower scope than the version quoted here.…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #120 · Clinical › Prescriber conversations · 11 Dec 2024 · 5 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #58 · Compounds › Semaglutide · 3 Dec 2024 · 7 likes The arithmetic in post #57 is right; the assumption feeding it is the part to check. On the injection-day question: the labelling for licensed semaglutide allows the…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #91 · Clinical › Prescriber conversations · 23 Nov 2024 · 30 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Revisiting: Moderation log format change Replied, post #36 · Meta › Announcements · 21 Nov 2024 · 5 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #74 · Clinical › Prescriber conversations · 18 Nov 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Promotion criteria, and the one that stops most nominations Replied, post #16 · Documentation › Doc review · 11 Jul 2024 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. A promotion that is declined should leave the topic linked from wherever the…
The mass-error checker and its intended scope Replied, post #106 · Data & Tools › Calculators · 8 Jul 2024 · 29 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Assessing a warm arrival: the decision process — one year on Replied, post #60 · Sourcing › Logistics · 30 May 2024 · 10 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. Take the reasoning and check the arithmetic; I do not…